title: [Prostatic carcinoma: current status of diagnostic imaging].
abstract: Prostate carcinoma showed a strong increase in industrial countries and today it is the second common cause of cancer related death. Prostate specific antigen allows early detection of prostate cancer, US-guided biopsy is employed for proof of diagnosis. The role of imaging has been discussed very contrarily. However, different options for treatment of prostate cancer and last but not least technological advances of different imaging modalities seem to reassess the role of imaging in prostate cancer.
authors.affiliation: Universitätsklinik für Radiodiagnostik, Währinger Gürtel 18-20, A-1090 Wien. nicolas.bloch@univie.ac.at
authors.forename: B N
authors.initials: BN
authors.lastname: Bloch
authors.forename: T
authors.initials: T
authors.lastname: Helbich
authors.forename: Gertraud
authors.initials: G
authors.lastname: Heinz-Peer
mesh_terms: D001707:Biopsy, Needle; D003952:Diagnostic Imaging; D019160:Endosonography; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009367:Neoplasm Staging; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology; D012680:Sensitivity and Specificity; D036542:Tomography, Spiral Computed